Alert detail
FDA Approval: TRYNGOLZA (OLEZARSEN SODIUM) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA218614Specialty: Multi-specialtyAdded: 6/27/2026Effective: 2024-12-19billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.